Semi-Annual Consolidated Statement Of Cash Flows

COSMOS Pharmaceutical Corporation - Filing #7310433

Concept 2023-06-01 to
2024-05-31
As at
2024-05-31
As at
2023-05-31
2022-06-01 to
2023-05-31
As at
2022-05-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
63,878,000,000 JPY
63,475,000,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-101,000,000 JPY
-51,000,000 JPY
Income taxes paid
-8,993,000,000 JPY
-9,111,000,000 JPY
Net cash provided by (used in) operating activities
55,175,000,000 JPY
54,434,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-55,810,000,000 JPY
-46,636,000,000 JPY
Proceeds from sale of property, plant and equipment
718,000,000 JPY
46,000,000 JPY
Other, net
-1,116,000,000 JPY
-958,000,000 JPY
Net cash provided by (used in) investing activities
-57,329,000,000 JPY
-49,113,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
18,400,000,000 JPY
10,000,000,000 JPY
Repayments of long-term borrowings
-3,193,000,000 JPY
-1,628,000,000 JPY
Purchase of treasury shares
0 JPY
0 JPY
Dividends paid
-4,659,000,000 JPY
-3,266,000,000 JPY
Net cash provided by (used in) financing activities
8,527,000,000 JPY
3,245,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
6,373,000,000 JPY
8,566,000,000 JPY
Cash and cash equivalents
52,301,000,000 JPY
45,928,000,000 JPY
37,362,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.